심혈관 디지털 솔루션 시장 : 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

The Global Cardiovascular Digital Solutions Market was valued at USD 95.5 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2032. The market expansion is fueled by the rising prevalence of cardiac conditions, technological strides in telehealth, and heightened awareness and accessibility of emerging products.

Telehealth's technological advancements play a pivotal role in propelling the market growth. These innovations not only bolster the monitoring and diagnosis of cardiovascular conditions but also cater to the surging demand for remote healthcare solutions. Wearable technologies, including smartwatches and fitness trackers with ECG (electrocardiogram) sensors, are transforming the landscape of cardiovascular care. Such devices facilitate the continuous monitoring of heart rhythms, blood pressure, and other vital signs for delivering real-time data to patients and healthcare professionals. This capability to detect anomalies promptly and monitor health trends remotely is a primary catalyst for the market growth.

The overall industry is application, component, deployment mode, end-use, and region.

The market is segmented by application into cardiac monitoring and diagnosis, CVD health informatics, cardiac rehab programs, and other areas. Dominating the market, the cardiac monitoring and diagnosis segment was valued at USD 56.9 billion in 2023. Given that cardiovascular diseases (CVDs) rank among the top global causes of morbidity and mortality, the prevalent conditions like hypertension, arrhythmias, and coronary artery disease underscore the demand for precise diagnostic tools and continuous monitoring.

Deployment-wise, the market is divided into cloud-based and on-premise solutions. In 2023, cloud-based solutions commanded a dominant market share of 53.2%. These cloud solutions provide a scalable infrastructure, enabling healthcare providers to adjust resources seamlessly in response to demand fluctuations. Such adaptability is vital for managing diverse patient data volumes and enhancing capabilities as required.

In 2023, North America cardiovascular digital solutions market was valued at USD 35.5 billion, with projections indicating a CAGR of 5.4% during the analysis period. The region's high prevalence of cardiovascular diseases, such as coronary artery disease and hypertension, fuels the demand for digital solutions that ensure continuous monitoring and sophisticated diagnostics. Furthermore, North America's robust healthcare infrastructure and its widespread embrace of digital health technologies streamline the integration and application of cardiovascular digital solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of cardiac conditions
    • 3.2.1.2 Technological advancements in telehealth
    • 3.2.1.3 Rising awareness and accessibility of the new products
    • 3.2.1.4 Growing adoption of data driven healthcare model
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Data security concerns
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends
• 3.9 GAP analysis
• 3.10 Policy landscape

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiac monitoring and diagnosis
• 5.3 CVD health informatics
• 5.4 Cardiac rehab programs
• 5.5 Other applications

Chapter 6 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Devices
• 6.3 Software

Chapter 7 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Cloud-based
• 7.3 On-premise

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Homecare
• 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 AliveCor, Inc.
• 10.2 Apple Inc.
• 10.3 Baxter
• 10.4 Cardiac Insight, Inc.
• 10.5 Cardiotrack
• 10.6 eviCore healthcare
• 10.7 Garmin
• 10.8 GE Healthcare
• 10.9 HeartFlow
• 10.10 iRhythm Technologies, Inc.
• 10.11 Myia Health
• 10.12 Omron Healthcare
• 10.13 Qardio
• 10.14 Verily Life Sciences LLC,
• 10.15 Welch Allyn